|
|
Volumn 33, Issue 2, 1998, Pages 159-164
|
|
Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?
a
|
|
Author keywords
Anti androgen monotherapy; Bicalutamide; Flutamide; Nilutamide; Prostate cancer
|
|
Indexed keywords
ANTIANDROGEN;
BICALUTAMIDE;
FLUTAMIDE;
NILUTAMIDE;
NON STEROIDAL ANTIANDROGEN;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
ALCOHOL METABOLISM;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER PALLIATIVE THERAPY;
CANCER PATIENT;
CANCER SURGERY;
CANCER SURVIVAL;
CASTRATION;
CLINICAL PRACTICE;
CLINICAL TRIAL;
DISEASE COURSE;
DOSE CALCULATION;
DRUG EFFICACY;
DRUG TOLERABILITY;
HORMONAL THERAPY;
HUMAN;
IMPOTENCE;
LIBIDO;
LIVER DISEASE;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
METASTASIS;
ORCHIECTOMY;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
RESPIRATORY TRACT DISEASE;
SYMPTOM;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT PLANNING;
VISUAL DISORDER;
ANDROGEN ANTAGONISTS;
ANILIDES;
CLINICAL TRIALS;
FLUTAMIDE;
HUMANS;
IMIDAZOLES;
IMIDAZOLIDINES;
MALE;
PROSTATIC NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0031883523
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000019548 Document Type: Article |
|
Times cited : (29)
|
|
References (41)
|
